| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.006 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |